Segall Bryant & Hamill’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29M | Sell |
224,163
-40,832
| -15% | -$5.87M | 0.41% | 63 |
|
|
2025
Q4 | $37.8M | Sell |
264,995
-15,526
| -6% | -$2.08M | 0.51% | 41 |
|
|
2025
Q3 | $33.7M | Sell |
280,521
-15,154
| -5% | -$1.92M | 0.45% | 56 |
|
|
2025
Q2 | $39.1M | Sell |
295,675
-2,000
| -0.7% | -$271K | 0.55% | 39 |
|
|
2025
Q1 | $41.3M | Sell |
297,675
-9,142
| -3% | -$1.42M | 0.63% | 26 |
|
|
2024
Q4 | $47.6M | Sell |
306,817
-26,627
| -8% | -$4.5M | 0.66% | 24 |
|
|
2024
Q3 | $60.8M | Sell |
333,444
-116,778
| -26% | -$17.3M | 0.83% | 9 |
|
|
2024
Q2 | $53.5M | Sell |
450,222
-34,413
| -7% | -$3.62M | 0.95% | 12 |
|
|
2024
Q1 | $52M | Buy |
484,635
+155
| +0% | +$15.4K | 0.97% | 16 |
|
|
2023
Q4 | $48.3M | Buy |
484,480
+21,614
| +5% | +$2.11M | 0.93% | 16 |
|
|
2023
Q3 | $55.1M | Buy |
462,866
+90,126
| +24% | +$13.4M | 0.64% | 33 |
|
|
2023
Q2 | $66.4M | Buy |
372,740
+1,743
| +0.5% | +$320K | 0.69% | 29 |
|
|
2023
Q1 | $61.2M | Sell |
370,997
-5,744
| -2% | -$988K | 0.66% | 33 |
|
|
2022
Q4 | $59.3M | Sell |
376,741
-2,941
| -0.8% | -$448K | 0.66% | 36 |
|
|
2022
Q3 | $57.2M | Buy |
379,682
+7,418
| +2% | +$1.23M | 0.68% | 30 |
|
|
2022
Q2 | $61.2M | Buy |
372,264
+110,658
| +42% | +$21.3M | 0.69% | 36 |
|
|
2022
Q1 | $58.2M | Buy |
261,606
+73,814
| +39% | +$16.5M | 0.56% | 45 |
|
|
2021
Q4 | $44.6M | Buy |
187,792
+7,603
| +4% | +$1.78M | 0.41% | 76 |
|
|
2021
Q3 | $42.1M | Buy |
180,189
+17,304
| +11% | +$3.63M | 0.4% | 72 |
|
|
2021
Q2 | $33.5M | Buy |
162,885
+27,139
| +20% | +$5.58M | 0.33% | 87 |
|
|
2021
Q1 | $27.9M | Buy |
135,746
+11,158
| +9% | +$2.36M | 0.28% | 101 |
|
|
2020
Q4 | $26.7M | Buy |
124,588
+13,303
| +12% | +$2.58M | 0.3% | 93 |
|
|
2020
Q3 | $20.3M | Buy |
111,285
+46,671
| +72% | +$8.79M | 0.28% | 90 |
|
|
2020
Q2 | $11.9M | Buy |
64,614
+28,767
| +80% | +$5.71M | 0.2% | 112 |
|
|
2020
Q1 | $7.23M | Sell |
35,847
-7,457
| -17% | -$1.44M | 0.15% | 142 |
|
|
2019
Q4 | $8.1M | Buy |
43,304
+234
| +0.5% | +$40.3K | 0.13% | 169 |
|
|
2019
Q3 | $6.88M | Sell |
43,070
-57,062
| -57% | -$11.4M | 0.11% | 224 |
|
|
2019
Q2 | $25.2M | Buy |
100,132
+477
| +0.5% | +$111K | 0.38% | 63 |
|
|
2019
Q1 | $23.9M | Sell |
99,655
-2,627
| -3% | -$630K | 0.37% | 65 |
|
|
2018
Q4 | $23.5M | Buy |
102,282
+12,292
| +14% | +$3.03M | 0.4% | 63 |
|
|
2018
Q3 | $25.4M | Buy |
89,990
+9,590
| +12% | +$2.81M | 0.37% | 63 |
|
|
2018
Q2 | $23.6M | Sell |
80,400
-5,947
| -7% | -$1.63M | 0.36% | 71 |
|
|
2018
Q1 | $21.8M | Sell |
86,347
-10,749
| -11% | -$2.53M | 0.5% | 50 |
|
|
2017
Q4 | $21M | Buy |
97,096
+29,361
| +43% | +$5.94M | 0.46% | 58 |
|
|
2017
Q3 | $12.6M | Buy |
+67,735
| New | +$11.8M | 0.29% | 87 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Segall Bryant & Hamill's ICUI Position: Q1 2026 in Review
Segall Bryant & Hamill reduced its ICU Medical (ICUI) stake by 15% in Q1 2026, selling an estimated $5.87M and leaving 224,163 shares worth $29M. The position accounts for 0.41% of the portfolio, ranked #63.
Segall Bryant & Hamill first reported a position in ICUI in Q3 2017 and has held it in 35 quarters since. The position peaked at $66.4M in Q2 2023. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Segall Bryant & Hamill held 224,163 shares of ICU Medical worth $29M as of Q1 2026.
- Segall Bryant & Hamill sold 40,832 ICU Medical shares in Q1 2026, an estimated $5.87M.
- ICU Medical made up 0.41% of Segall Bryant & Hamill's portfolio in Q1 2026, its #63 holding.
- Segall Bryant & Hamill first reported a position in ICU Medical in Q3 2017 and has held it in 35 quarters since.
- Segall Bryant & Hamill's ICU Medical position peaked at $66.4M in Q2 2023.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.